ArticleInternational journal of clinical and experimental pathology2020

Correlation of HER2 codon 655 polymorphism with cardiotoxicity risk in Chinese HER2-positive breast cancer patients undergoing epirubicin/cyclophosphamide followed by docetaxel plus trastuzumab adjuvant chemotherapy.

Lun Tan et al.PubMed ↗Full text ↗

No numbers read from the abstract.